KORU Medical Systems, Inc. (KRMD)
- Previous Close
2.3600 - Open
2.3700 - Bid 2.2500 x 500
- Ask 2.3200 x 200
- Day's Range
2.2600 - 2.3700 - 52 Week Range
1.9780 - 4.2950 - Volume
119,710 - Avg. Volume
119,223 - Market Cap (intraday)
104.342M - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2900 - Earnings Date Mar 6, 2024 - Mar 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.50
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
www.korumedical.comRecent News: KRMD
Performance Overview: KRMD
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KRMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KRMD
Valuation Measures
Market Cap
104.34M
Enterprise Value
97.69M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.55
Price/Book (mrq)
5.46
Enterprise Value/Revenue
3.33
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-45.24%
Return on Assets (ttm)
-17.44%
Return on Equity (ttm)
-54.24%
Revenue (ttm)
29.32M
Net Income Avi to Common (ttm)
-13.27M
Diluted EPS (ttm)
-0.2900
Balance Sheet and Cash Flow
Total Cash (mrq)
10.82M
Total Debt/Equity (mrq)
21.83%
Levered Free Cash Flow (ttm)
1.76M
Research Analysis: KRMD
Company Insights: KRMD
KRMD does not have Company Insights